Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI Summary - About
Koninklijke Philips NV ADR(PHG)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for PHG
10/26/2026: PHG (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Koninklijke Philips is a global health technology firm focused on diagnostic imaging, patient monitoring, and personal health solutions. The company is currently in a multi-year turnaround phase, aiming to improve operational efficiency and manufacturing quality following significant product recalls. While it maintains a leading market position in hospital hardware, its primary growth story relies on scaling high-margin health informatics and digital care platforms. Investors should weigh the company's strong brand and installed base against the ongoing financial and regulatory risks associated with historical device litigation. Philips may suit value-oriented investors who are willing to navigate volatility during the ongoing corporate restructuring.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | The company is in a turnaround phase rather than a high-growth expansion. |
| Momentum investor | Weak fit | The stock has struggled with momentum due to ongoing regulatory and legal overhangs. |
| Value investor | Strong fit | Valuations may appear attractive if the company successfully puts its major legal liabilities behind it. |
| Dividend investor | Mixed fit | Dividends exist, but they are vulnerable to fluctuations in legal and restructuring costs. |
| Low-risk investor | Weak fit | Regulatory risks and litigation create volatility that is unsuitable for conservative investors. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium / high | Legal and regulatory headlines frequently drive sharp price movements. |
| Valuation risk | Medium | Future earnings depend heavily on the final resolution of product-related lawsuits. |
| Competition risk (MedTech incumbents) | High | Heavy competition from well-capitalized rivals like Siemens and GE constrains pricing power. |
| Business quality | Medium | The company is shifting from a hardware-heavy model to software-integrated services, which is a work in progress. |
| Dividend income | Medium | The dividend is not guaranteed and depends on management's assessment of liquidity needs. |
| Execution risk | High | The company must improve its manufacturing quality systems to regain full regulatory trust. |
Price Behavior
Downtrend
The stock has experienced a sustained decline in price over recent periods.
Smooth
The stock has moved along a generally orderly path with only modest fluctuations.
Analysis of Past Performance
Type Stock | Historic Profit -17.06% | Avg. Invested days 32 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating  | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/26/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 26.28B USD | Price to earnings Ratio 20.07 | 1Y Target Price 32.02 |
Price to earnings Ratio 20.07 | 1Y Target Price 32.02 | ||
Volume (30-day avg) 1.1M shares | Beta 0.92 | 52 Weeks Range 23.62 - 32.19 | Updated Date 10/25/2026 |
52 Weeks Range 23.62 - 32.19 | Updated Date 10/25/2026 | ||
Dividends yield (FY) 3.77% | Basic EPS (TTM) 1.34 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Diagnosis & Treatment | Imaging systems, ultrasound, and image-guided therapy. | This is the core engine of the business, selling high-tech equipment to hospitals. |
| Connected Care | Patient monitoring, enterprise informatics, and telehealth. | This segment provides recurring software revenue for hospital efficiency. |
| Personal Health | Oral care, shavers, and sleep devices. | These consumer products provide brand visibility and stable cash flow. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2026-11-03 | When Before Market | Estimate 0.37 | Actual - |
Profitability
Profit Margin 6.31% | Operating Margin (TTM) 13.99% |
Management Effectiveness
Return on Assets (TTM) 4.07% | Return on Equity (TTM) 10.15% |
Valuation
Trailing PE 20.07 | Forward PE 12.72 | Enterprise Value 30.99B | Price to Sales(TTM) 1.49 |
Enterprise Value 30.99B | Price to Sales(TTM) 1.49 | ||
Enterprise Value to Revenue 1.53 | Enterprise Value to EBITDA 8.98 | Shares Outstanding 977.43M | Shares Floating 976.80M |
Shares Outstanding 977.43M | Shares Floating 976.80M | ||
Percent Insiders - | Percent Institutions 5.4 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.